Research

Edison

04 November 2022

Edison issues review on BioPharma Credit (BPCR)

Read more

Related articles

Related Industry News

Quoted data logo

Stable dividend boosts BioPharma Credit

BioPharma Credit (BPCR) announced its annual results for the year ended 31 December 2023. The company saw NAV growth of 1.5% over the period while mai...

Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.